| 000 | 01714 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515001229.0 | ||
| 264 | 0 | _c20050927 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1016/j.clpt.2005.06.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMagnusson, Yvonne | |
| 245 | 0 | 0 |
_aSer49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cSep 2005 |
||
| 300 |
_a221-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aCardiomyopathy, Dilated _xdrug therapy |
| 650 | 0 | 4 | _aCodon |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDNA _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aGlycine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-1 _xdrug effects |
| 650 | 0 | 4 | _aSerine |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLevin, Malin C | |
| 700 | 1 | _aEggertsen, Robert | |
| 700 | 1 | _aNyström, Ernst | |
| 700 | 1 | _aMobini, Reza | |
| 700 | 1 | _aSchaufelberger, Maria | |
| 700 | 1 | _aAndersson, Bert | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 78 _gno. 3 _gp. 221-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clpt.2005.06.004 _zAvailable from publisher's website |
| 999 |
_c15787139 _d15787139 |
||